首页> 外文OA文献 >Late Toxicities Differed Maximum Tolerated Dose Determined by Acute Toxicities: Reanalysis of a Phase I/II Trial of Dose Escalation in Unresectable Thoracic Esophageal Cancer by Simultaneous Integrated Boost

【2h】

Late Toxicities Differed Maximum Tolerated Dose Determined by Acute Toxicities: Reanalysis of a Phase I/II Trial of Dose Escalation in Unresectable Thoracic Esophageal Cancer by Simultaneous Integrated Boost

机译：通过急性毒性测定的晚期毒性不同：通过同时综合提升，通过同时综合提升分析不可切除的胸部食管癌剂量升级的相I / II试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
W. Yu; X.L. Fu; X.W. Cai; W. Feng; Q. Zhang; L.T. Gao;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Late Toxicities Differed Maximum Tolerated Dose Determined by Acute Toxicities: Reanalysis of a Phase I/II Trial of Dose Escalation in Unresectable Thoracic Esophageal Cancer by Simultaneous Integrated Boost [J] . Yu W., Fu X. L., Cai X. W., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：通过急性毒性测定的晚期毒性不同：通过同时综合提升，通过同时综合提升分析不可切除的胸部食管癌剂量升级的相I / II试验
2. A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer [J] . Chen Li, Wenjie Ni, Xin Wang, Radiation oncology . 2019,第1期

机译：一期I / II阶段放射剂量递增试验，采用同时整合增强技术结合选择性淋巴结照射和同步化疗治疗无法切除的食管癌
3. Radiation Dose Escalated Chemoradiotherapy Using Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Unresectable Thoracic Esophageal Squamous Cell Carcinoma: A Single Institutional Phase I Study [J] . Sakanaka K., Ishida Y., Fujii K., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：辐射剂量升级化学疗法使用同时集成升压强度调制放疗局部先进的不可切除胸部食管鳞状细胞癌：我研究的单一制度阶段
4. The Combination of Clinical, Dose-Related and Imaging Features Helps Predict Radiation-Induced Normal-Tissue Toxicity in Lung-cancer Patients -- An in-silico Trial Using Machine Learning Techniques [C] . Nalbantov G., Dekker A., De Ruysscher D., Machine Learning and Applications and Workshops (ICMLA), 2011 10th International Conference on . 2011

机译：临床，剂量相关和影像学特征的结合可帮助预测肺癌患者放射诱发的正常组织毒性-使用机器学习技术的计算机模拟试验
5. A robust paradigm of finding the maximum tolerated dose in Phase I cancer clinical trials with application to IL-21 denenicokin [D] . Young, Tina Chang. 2017

机译：在I期临床研究中将最大耐受剂量应用于IL-21 Denenicokin的最大范例
6. A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer [O] . Chen Li, Wenjie Ni, Xin Wang, 2019

机译：一期I / II阶段放射剂量递增试验采用同时整合增强技术结合选择性淋巴结照射和同步化疗治疗无法切除的食管癌
7. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial [O] . James W. Welsh, Steven N. Seyedin, Pamela K. Allen, 2017

机译：局部晚期食管癌剂量升级同时升高的局部控制和毒性：临时阶段I / II试验中的临时结果

Late Toxicities Differed Maximum Tolerated Dose Determined by Acute Toxicities: Reanalysis of a Phase I/II Trial of Dose Escalation in Unresectable Thoracic Esophageal Cancer by Simultaneous Integrated Boost

著录项

相似文献

相关主题

期刊订阅